본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Treatment Outcomes of Proton Beam Therapy for Esophageal Squamous Cell Carcinoma at a Single Institute Moon Sung Ho
(Department of Radiation oncology)

Oh Eun Sang
(Department of Radiation oncology)
. Treatment Outcomes of Proton Beam Therapy for Esophageal Squamous Cell Carcinoma at a Single Institute. CANCERS. 2023-11-22; 2023; 15(23):5524~. IF 5.2 (2022)
Hemoglobin Subunit Theta 1 Promotes Proliferation by Reducing Reactive Oxygen Species in Lung Adenocarcinoma Kim Youn Jae
(Targeted Therapy Branch)

KIM KYUNG HO
(Targeted Therapy Branch)
. Hemoglobin Subunit Theta 1 Promotes Proliferation by Reducing Reactive Oxygen Species in Lung Adenocarcinoma. CANCERS. 2023-11-21; 2023; 15(23):5504~. IF 5.2 (2022)
Latent tuberculosis infection in Korean patients with multiple sclerosis and neuromyelitis optica spectrum disorder Kim Ho Jin
(Department of Neurology)

Kim Ki Hoon
(Department of Neurology)
. Latent tuberculosis infection in Korean patients with multiple sclerosis and neuromyelitis optica spectrum disorder. MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023-11-21; 2023; 81:105145~. IF 4 (2022)
Proton pump inhibitors and risk of gastrointestinal cancer: A meta-analysis of cohort studies Myung, Seung-Kwon
(Department of Clinical Nursing Science)


()
. Proton pump inhibitors and risk of gastrointestinal cancer: A meta-analysis of cohort studies. ONCOLOGY LETTERS. 2023-11-20; 2023; 27(1):28~. IF 2.9 (2022)
Interaction between vitamin E intake and a COMT gene variant on colorectal cancer risk: a case-control study Kim Jeong seon
(Department of Cancer AI and Digital Health)


()
. Interaction between vitamin E intake and a COMT gene variant on colorectal cancer risk: a case-control study. EPIDEMIOLOGY AND HEALTH. 2023-11-14; 2023; 45:e2023100~. IF 3.8 (2022)
Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review Lee Eun Kyung
(Targeted Therapy Branch)


()
. Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review. ENDOCRINOLOGY AND METABOLISM. 2023-11-13; 2023; 38(6):750~759. IF 3.4 (2022)
Delirium in patients with COVID-19 treated in the intensive care unit Kim Jee Hee
(Department of Intensive Care)

Lee Jae Hoon
(Department of Intensive Care)
. Delirium in patients with COVID-19 treated in the intensive care unit. PLOS ONE. 2023-11-13; 2023; 18(11):e0289662~. IF 3.7 (2022)
Effects of life-sustaining treatment plans on healthcare expenditure and healthcare utilization
()

Jeong Won Jeong
(Cancer Information & Education Center)
. Effects of life-sustaining treatment plans on healthcare expenditure and healthcare utilization. BMC HEALTH SERVICES RESEARCH. 2023-11-10; 2023; 23(1):1236~. IF 2.8 (2022)
Dietary and supplementary vitamin C intake and the risk of lung cancer: A meta-analysis of cohort studies Myung, Seung-Kwon
(Department of Clinical Nursing Science)

Van Dung TRAN
(Department of Cancer Control and Population Health)
. Dietary and supplementary vitamin C intake and the risk of lung cancer: A meta-analysis of cohort studies. ONCOLOGY LETTERS. 2023-11-10; 2023; 27(1):10~. IF 2.9 (2022)
Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis LIM MYONG CHEOL
(Rare & Pediatric Cancer Branch)

Kim Ji Hyun
(Department of Obstetrics and Gynecology)
. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023-11-10; 2023; 33(12):1913~1920. IF 4.8 (2022)
First page Prev paging 31 32 33 34 35 36 37 38 39 40 next paging last page